CTRI/2014/10/005085RecruitingPhase 1/2
A STUDY ON VYANABALA VRIDDHI (ESSENTIAL HYPERTENSION) AND ITS MANAGEMENT WITH JATAMANSYADI VATI
Institute for Post Graduate Teaching And Research in Ayurveda1 site in 1 country40 target enrollmentStarted: July 4, 2014Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 1/2
- Status
- Recruiting
- Sponsor
- Enrollment
- 40
- Locations
- 1
- Primary Endpoint
- control of hypertension
Study Overview
Brief Summary
This is a randomized control clinical trial at I P G T and R A, Gujarat Ayurved University, Jamnagar in Department of Kayachikitsa OPD. Dealing with treatment of Vyanabala Vriddhi (essential hypertension). In present study Jatamansyadi Vati which contain Jatamansi, Ashwagandha, Arjuna, Gokshura and Brahmi in equal parts will be given 1 gm BD for 28 days as interventional group. In control group Metoprolol will be given 25 mg or 50 mg OD for 28 days.
Study Design
- Study Type
- Interventional
- Allocation
- Coin toss, Lottery, toss of dice, shuffling cards etc
- Masking
- Not Applicable
Eligibility Criteria
- Ages
- 25.00 Year(s) to 65.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •Patients above 25 years and below 65 years of age will be selected for the study Patients with systolic blood pressure above 140 mm of Hg and below 180 mm of Hg will be taken for the study Patients with diastolic blood pressure above 90 mm of Hg and below 110 mm of Hg will be taken for the study Patients presenting with the classical symptoms of Hypertension will be taken for the study.
Exclusion Criteria
- •Patients below 25 years and above 65 years of age will be excluded from the study Patients with systolic blood pressure below 140 mm of Hg and above 180 mm of Hg will be excluded from the study Patients with diastolic blood pressure below 90 mm of Hg and above 110 mm of Hg will be excluded from the study Patients having major illness like severe D.M., tuberculosis, major endocrine disorders, malignancies, HIV, renal failure will be excluded from the study Patients having accelerated and malignant hypertension and history of cardiac compromise like angina, MI, CCF will also be excluded.
Outcomes
Primary Outcomes
control of hypertension
Time Frame: 28 days
Secondary Outcomes
- improve quality of life(after 28 days)
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
A clinical trial to know the effect of Virulina® along with standard treatment in covid 19 positive patients.Coronavirus as the cause of diseases classified elsewhere,CTRI/2020/06/025556Natural Solutions30
Not yet recruiting
Not Applicable
Ayurvedic Management of Pulmonary Eosinophilia- A Clinical StudyPulmonary eosinophilia, not elsewhere classified. Ayurveda Condition: EA-3.2 MORBIDITY CODE FOR VATAJA KASA, (2) ICD-10 Condition: J82||Pulmonary eosinophilia, not elsewhere classified, (3) ICD-10 Condition: J82||Pulmonary eosinophilia, not elsewhere classified,CTRI/2022/06/043421Dr Manjushri P30
Not yet recruiting
Phase 2
A CLINICAL STUDY TO EVALUATE THE EFFICACY OF VRINDAMADHAVOKTA DASHAMULAADI KASHAYA IN THE MANAGEMENT OF GRIDHRASI WITH SPECIAL REFERENCE TO SCIATICALumbago with sciatica. Ayurveda Condition: GRUDHRASI,CTRI/2022/07/043799Snehal Navnath Jagtap33
Recruiting
Not Applicable
Management of sciatica through enema and oral intake medicated oil.Other specified acquired deformities of musculoskeletal system,CTRI/2019/02/017470Rishikul campus40
Not yet recruiting
Phase 3
Varma thadaval for kumbavatham with varmam vatha ennaiCTRI/2021/07/035149PS Devika